PHI with Ulcerative ileocolitis
How does this condition affect your private health insurance?
Ulzeröse Ileokolitis, often referred to as Ulcerative Colitis with ileal involvement (backwash ileitis), is a chronic inflammatory bowel disease primarily affecting the large intestine, but in this specific form, also includes inflammation of the terminal ileum. It causes persistent inflammation and ulcers in the inner lining of the colon and ileum. Symptoms include severe abdominal pain, bloody diarrhea, rectal bleeding, tenesmus, weight loss, and fatigue. The disease follows a relapsing-remitting course, with periods of active inflammation alternating with remission. Complications can include toxic megacolon, anemia, and an increased risk of colorectal cancer. Management involves anti-inflammatory drugs, immunosuppressants, biologics, and sometimes surgical intervention like colectomy.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several weeks to months, depending on severity and treatment response.
Duration of Illness (Lifetime)
Chronic, lifelong disease with periods of remission and flare-ups requiring continuous management.
Cost of Treatment (Initial)
Several thousand to tens of thousands of USD, potentially higher with hospitalization and initial biologic therapy.
Cost of Treatment (Lifetime)
Hundreds of thousands to over a million USD, depending on disease severity, medication type (especially biologics), and need for surgeries.
Mortality Rate
Low but not negligible (<5%), mainly due to severe complications like toxic megacolon, overwhelming infection, severe hemorrhage, or surgical risks; long-term increased risk of colorectal cancer.
Risk of Secondary Damages
High (e.g., 30-50% or more), including anemia, malnutrition, osteoporosis, arthritis, skin manifestations, eye inflammation, primary sclerosing cholangitis, and significant psychological impact such as anxiety and depression.
Probability of Full Recovery
Very low (<5%) without surgery, as it is a chronic disease requiring ongoing management. Total colectomy can effectively cure the colonic disease but involves its own consequences and does not eliminate potential extra-intestinal manifestations.
Underlying Disease Risk
Low for other specific diseases being the direct cause of Ulzeröse Ileokolitis. However, there is an increased prevalence (e.g., 10-20%) of other autoimmune conditions (e.g., primary sclerosing cholangitis, ankylosing spondylitis) occurring concurrently or subsequently.